vs

Side-by-side financial comparison of FVCBankcorp, Inc. (FVCB) and Outset Medical, Inc. (OM). Click either name above to swap in a different company.

Outset Medical, Inc. is the larger business by last-quarter revenue ($28.9M vs $16.9M, roughly 1.7× FVCBankcorp, Inc.). On growth, FVCBankcorp, Inc. posted the faster year-over-year revenue change (4377.5% vs -2.0%). FVCBankcorp, Inc. produced more free cash flow last quarter ($23.8M vs $-9.7M). Over the past eight quarters, FVCBankcorp, Inc.'s revenue compounded faster (586.6% CAGR vs 1.2%).

FVCBankcorp, Inc. is a Virginia-based U.S. bank holding company operating FVCbank, a community-focused financial institution. It provides a full range of personal and commercial banking products including deposit accounts, business and personal loans, mortgage services, and wealth management solutions, serving SMEs, professionals and individual consumers across the Mid-Atlantic region.

Outset Medical, Inc. is a medical technology company focused on developing and commercializing innovative dialysis solutions for patients living with kidney disease. Its flagship Tablo Hemodialysis System supports use in acute care facilities, outpatient clinics, and home settings, serving healthcare providers and patients across the U.S. and select international markets.

FVCB vs OM — Head-to-Head

Bigger by revenue
OM
OM
1.7× larger
OM
$28.9M
$16.9M
FVCB
Growing faster (revenue YoY)
FVCB
FVCB
+4379.5% gap
FVCB
4377.5%
-2.0%
OM
More free cash flow
FVCB
FVCB
$33.6M more FCF
FVCB
$23.8M
$-9.7M
OM
Faster 2-yr revenue CAGR
FVCB
FVCB
Annualised
FVCB
586.6%
1.2%
OM

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
FVCB
FVCB
OM
OM
Revenue
$16.9M
$28.9M
Net Profit
$-19.5M
Gross Margin
42.4%
Operating Margin
43.7%
-61.1%
Net Margin
-67.5%
Revenue YoY
4377.5%
-2.0%
Net Profit YoY
24.0%
EPS (diluted)
$0.31
$0.33

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
FVCB
FVCB
OM
OM
Q4 25
$16.9M
$28.9M
Q3 25
$416.0K
$29.4M
Q2 25
$15.8M
$31.4M
Q1 25
$382.0K
$29.8M
Q4 24
$378.0K
$29.5M
Q3 24
$412.0K
$28.7M
Q2 24
$415.0K
$27.4M
Q1 24
$359.0K
$28.2M
Net Profit
FVCB
FVCB
OM
OM
Q4 25
$-19.5M
Q3 25
$5.6M
$-17.8M
Q2 25
$5.7M
$-18.5M
Q1 25
$5.2M
$-25.8M
Q4 24
$-25.6M
Q3 24
$4.7M
$-27.9M
Q2 24
$4.2M
$-34.5M
Q1 24
$1.3M
$-39.9M
Gross Margin
FVCB
FVCB
OM
OM
Q4 25
42.4%
Q3 25
39.4%
Q2 25
37.8%
Q1 25
37.2%
Q4 24
36.5%
Q3 24
34.3%
Q2 24
35.7%
Q1 24
29.2%
Operating Margin
FVCB
FVCB
OM
OM
Q4 25
43.7%
-61.1%
Q3 25
-53.7%
Q2 25
45.9%
-53.7%
Q1 25
-55.1%
Q4 24
-74.2%
Q3 24
-83.2%
Q2 24
-112.3%
Q1 24
-131.0%
Net Margin
FVCB
FVCB
OM
OM
Q4 25
-67.5%
Q3 25
1341.1%
-60.6%
Q2 25
36.0%
-59.0%
Q1 25
1352.1%
-86.7%
Q4 24
-87.0%
Q3 24
1133.3%
-97.5%
Q2 24
1001.2%
-125.8%
Q1 24
373.3%
-141.8%
EPS (diluted)
FVCB
FVCB
OM
OM
Q4 25
$0.31
$0.33
Q3 25
$0.31
$-1.00
Q2 25
$0.31
$-1.04
Q1 25
$0.28
$-3.66
Q4 24
$0.27
$-7.21
Q3 24
$0.25
$-8.02
Q2 24
$0.23
$-9.96
Q1 24
$0.07
$-11.77

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
FVCB
FVCB
OM
OM
Cash + ST InvestmentsLiquidity on hand
$168.9M
Total DebtLower is stronger
$96.2M
Stockholders' EquityBook value
$253.6M
$127.0M
Total Assets
$2.3B
$264.5M
Debt / EquityLower = less leverage
0.76×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
FVCB
FVCB
OM
OM
Q4 25
$168.9M
Q3 25
$178.6M
Q2 25
$184.1M
Q1 25
$189.0M
Q4 24
$158.7M
Q3 24
$175.6M
Q2 24
$194.8M
Q1 24
$226.9M
Total Debt
FVCB
FVCB
OM
OM
Q4 25
$96.2M
Q3 25
Q2 25
Q1 25
Q4 24
$197.4M
Q3 24
Q2 24
Q1 24
Stockholders' Equity
FVCB
FVCB
OM
OM
Q4 25
$253.6M
$127.0M
Q3 25
$249.8M
$142.4M
Q2 25
$243.2M
$154.8M
Q1 25
$242.3M
$169.9M
Q4 24
$235.4M
$26.8M
Q3 24
$230.8M
$47.8M
Q2 24
$226.5M
$68.6M
Q1 24
$220.7M
$93.2M
Total Assets
FVCB
FVCB
OM
OM
Q4 25
$2.3B
$264.5M
Q3 25
$2.3B
$277.3M
Q2 25
$2.2B
$288.8M
Q1 25
$2.2B
$301.2M
Q4 24
$2.2B
$275.8M
Q3 24
$2.3B
$292.9M
Q2 24
$2.3B
$314.5M
Q1 24
$2.2B
$346.2M
Debt / Equity
FVCB
FVCB
OM
OM
Q4 25
0.76×
Q3 25
Q2 25
Q1 25
Q4 24
7.36×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
FVCB
FVCB
OM
OM
Operating Cash FlowLast quarter
$23.9M
$-9.5M
Free Cash FlowOCF − Capex
$23.8M
$-9.7M
FCF MarginFCF / Revenue
140.7%
-33.7%
Capex IntensityCapex / Revenue
0.3%
0.8%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$40.0M
$-47.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
FVCB
FVCB
OM
OM
Q4 25
$23.9M
$-9.5M
Q3 25
$7.6M
$-6.3M
Q2 25
$3.3M
$-4.8M
Q1 25
$5.4M
$-25.7M
Q4 24
$18.2M
$-16.5M
Q3 24
$4.7M
$-20.6M
Q2 24
$1.6M
$-33.3M
Q1 24
$7.2M
$-45.9M
Free Cash Flow
FVCB
FVCB
OM
OM
Q4 25
$23.8M
$-9.7M
Q3 25
$7.6M
$-6.5M
Q2 25
$3.3M
$-5.1M
Q1 25
$5.4M
$-25.8M
Q4 24
$18.1M
$-16.5M
Q3 24
$4.6M
$-21.0M
Q2 24
$1.5M
$-33.5M
Q1 24
$7.1M
$-46.3M
FCF Margin
FVCB
FVCB
OM
OM
Q4 25
140.7%
-33.7%
Q3 25
1818.0%
-22.0%
Q2 25
20.8%
-16.3%
Q1 25
1413.6%
-86.7%
Q4 24
4786.0%
-56.1%
Q3 24
1121.8%
-73.1%
Q2 24
361.2%
-122.2%
Q1 24
1988.3%
-164.3%
Capex Intensity
FVCB
FVCB
OM
OM
Q4 25
0.3%
0.8%
Q3 25
0.2%
0.5%
Q2 25
0.1%
0.9%
Q1 25
4.2%
0.4%
Q4 24
37.3%
0.1%
Q3 24
14.1%
1.4%
Q2 24
12.8%
0.4%
Q1 24
3.9%
1.3%
Cash Conversion
FVCB
FVCB
OM
OM
Q4 25
Q3 25
1.36×
Q2 25
0.58×
Q1 25
1.05×
Q4 24
Q3 24
1.00×
Q2 24
0.37×
Q1 24
5.34×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

FVCB
FVCB

Segment breakdown not available.

OM
OM

Consumables Product$13.5M47%
Service And Other Revenue$9.0M31%
Consoles Product$6.4M22%

Related Comparisons